PRINCIPAL HEALTHCARE INNOVATORS INDEX ETF News

ETF Trends CEO Tom Lydon says information technology ETFs are good picks as investors flock to ETFs most haven't heard of.

This is a weekly series focused on analyzing the previous week’s economic data releases. The objective is to concentrate on leading indicators of economic activ

These ETF areas showered gains in the lockdown-infected April.

As the U.S. economy reopens, Wall Street may remain charged up, benefiting high-beta ETFs. Investors can tap those with cheaper valuation.

As the U.S. economy reopens, Wall Street may remain charged up, benefiting high-beta ETFs. Investors can tap those with cheaper valuation.

The most negative impacts that we are seeing are among the consumer-facing healthcare businesses with services that are easily deferrable. Among the most resili

Here’s something to take some of the sting out of hard investing decisions. I call it the 3 Cs of trading in a crisis. Capital. Conviction. Courage. In order to

Stocks Analysis by Zacks Investment Research covering: Nasdaq 100, S&P 500, Barclays PLC, SPDR S&P 500. Read Zacks Investment Research's latest article on Investing.com

Despite the coronavirus concerns that have hit commodity markets and, in turn, energy and basic materials stocks, U.S. tech stocks have posted strong returns to

US healthcare is always a political hot potato, and volatility is expected to rise as the November elections approach. The US healthcare sector traded at a pric

The Trump Administration is considering reforms in the payment for prescription drugs covered under Medicare Part B. The changes include ones that could be acco

Stocks Analysis by Zacks Investment Research covering: Nasdaq 100, S&P 500, Intel Corporation, Microsoft Corporation. Read Zacks Investment Research's latest article on Investing.com

In a year-end poll of our Fundamental Active Equity investors, two themes stood out: The U.S. election is seen as a key market driver, and healthcare is among o

Here is a look at the 25 best and 25 worst ETFs from the past week. Traders can use this list to find prospective candidates that have deviated too far from their longer-term trends, thereby serving a

Increasing M&A; deals, growing AI dominance and favorable regulatory tidings continue to work in favor of the biotech market.